Skip to content

ClearPoint Neuro CLPT Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

IAR
Integra LifeSciencesIART
$174.05M-0.9%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$11.44M-14.4%
AngioDynamics logo
AngioDynamicsANGO
$5.49M+24.9%
Globus Medical logo
Globus MedicalGMED
$115.22M+24.8%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$439.87M-5.9%
BioLife Solutions logo
BioLife SolutionsBLFS
$12.36M-11.7%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: ClearPoint Neuro’s 10-K, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's operating lease liabilities (total)?
ClearPoint Neuro (CLPT) reported operating lease liabilities (total) of $9.16M in Q4 2025.
How has ClearPoint Neuro's operating lease liabilities (total) changed year-over-year?
ClearPoint Neuro's operating lease liabilities (total) increased by 156.6% year-over-year, from $3.57M to $9.16M.
What is the long-term trend for ClearPoint Neuro's operating lease liabilities (total)?
Over 5 years (2020 to 2025), ClearPoint Neuro's operating lease liabilities (total) has grown at a 25.3% compound annual growth rate (CAGR), from $2.96M to $9.16M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.